<DOC>
	<DOCNO>NCT01913093</DOCNO>
	<brief_summary>To find possible therapeutic target help prevent long-term brain behavioural side effect survivor childhood leukemia may cause chemotherapy ( Treatment-Related late Adverse Neuro-Cognitive Effects : TRANCE ) . The study hypothesis genetic variation element folate-related cycle methotrexate disposition network associate TRANCE phenotype childhood leukemia survivor .</brief_summary>
	<brief_title>N-PhenoGENICS : Neurocognitive-Phenome , Genome , Epigenome Nutriome In Childhood Leukemia Survivors</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<criteria>Past diagnosis acute lymphoblastic leukemia 8 year : 0 month 20 year : 11 month old time study visit At least 2 year : 0 month last treatment acute lymphoblastic leukemia time study visit Continuous complete remission undergone bone marrow transplantation Fluent English ( subject one parent ) test completion Signed informed consent Inability complete phenotyping test Down Syndrome diagnosis</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Childhood leukemia survivor</keyword>
	<keyword>Acute lymphoblastic leukemia</keyword>
	<keyword>Leukemia</keyword>
	<keyword>Late effect</keyword>
	<keyword>Folate</keyword>
	<keyword>Blood folate</keyword>
	<keyword>Neurotoxicity</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Cognitive</keyword>
	<keyword>Cognitive late effect</keyword>
	<keyword>N-PhenoGENICS</keyword>
</DOC>